Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Licenses Patents to Maker of Handheld Bioagent Detection Devices

NEW YORK, Dec. 12 - Cepheid granted Baltimore-based Environmental Technologies Group a sublicense to key patents for development of rapid, hand-held DNA analysis systems for bioagent detection, the company said on Wednesday.


The sublicense is worldwide and non-exclusive, and grants ETG rights to patented component designs for performing and monitoring analytical reactions, such as PCR, used in DNA detection on a hand-held device using battery power. Cepheid retains rights to commercialize hand-held systems for all other DNA-testing applications, including environmental testing and veterinary diagnostics, according to the company.


Cepheid and ETG have a US Department of Defense contract to deliver hand-held biological detection devices.


Cepheid, based in Sunnyvale, Calif., will receive royalties on ETG sales of the hand-held bioagent detection device. Financial details of the agreement were not disclosed.


"Cepheid views this new agreement as a continuation of our partnership with ETG in the area of bioagent detection for both military and homeland security applications," Tom Gutshall, CEO of Cepheid, said in a statement. "This agreement leverages the combined strengths of both companies across a range of markets, and presents a valuable opportunity for Cepheid to apply our core patents to development of a hand-held device."


Cepheid holds the exclusive license to these analytical reaction design patents from the University of California and Lawrence Livermore National Laboratories.



The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.